"Mercy Medical Center is a hospital in Cedar Rapids, IA, delivering The Mercy Touch by partnering technology with compassionate & high-quality patient care."

During the past decade, Mercy Hospital conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 65 clinical trials were completed, i.e. on average, 106.6% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 29 clinical trials were completed. i.e. 116% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "SWOG Cancer Research Network" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Hospital" are "Recurrent Breast Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (7 trials), "HER2/Neu Negative" (6 trials), "Adult Glioblastoma" (5 trials) and "Adult Gliosarcoma" (5 trials). Many other conditions were trialed in "Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Mercy Hospital" are "Drug" (109 trials), "Other" (88 trials), "Biological" (58 trials), "Procedure" (32 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (37 trials), "Paclitaxel" (22 trials), "Carboplatin" (19 trials) and "Bevacizumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Hospital" are 110 trials for "All" genders, 20 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Hospital". undefined are not yet recruiting, 25 are recruiting, 66 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Mercy Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Hospital, 5 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Mercy Hospital has several departments that took part in Clinical trials: "Oncology Associates at Mercy Medical Center" - 267 trials, "Iowa Blood and Cancer Care" - 25 trials